Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.
2.

1Hepatitis C virus NS5A protein modulates c-Jun N-terminal kinase through interaction with tumor necrosis factor receptor-associated factor 2.

Park KJ, Choi SH, Choi DH, Park JM, Yie SW, Lee SY, Hwang SB.

J Biol Chem. 2003 Aug 15;278(33):30711-8. Epub 2003 Jun 7.

3.

Hepatitis C virus core protein potentiates c-Jun N-terminal kinase activation through a signaling complex involving TRADD and TRAF2.

Park KJ, Choi SH, Koh MS, Kim DJ, Yie SW, Lee SY, Hwang SB.

Virus Res. 2001 Apr;74(1-2):89-98.

PMID:
11226577
4.
5.

Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.

Takada Y, Ichikawa H, Pataer A, Swisher S, Aggarwal BB.

Oncogene. 2007 Feb 22;26(8):1201-12. Epub 2006 Aug 21.

PMID:
16924232
6.

Nonstructural 5A protein of hepatitis C virus modulates tumor necrosis factor alpha-stimulated nuclear factor kappa B activation.

Park KJ, Choi SH, Lee SY, Hwang SB, Lai MM.

J Biol Chem. 2002 Apr 12;277(15):13122-8. Epub 2002 Jan 30.

7.

Tumor necrosis factor alpha-induced activation of c-jun N-terminal kinase is mediated by TRAF2.

Reinhard C, Shamoon B, Shyamala V, Williams LT.

EMBO J. 1997 Mar 3;16(5):1080-92.

8.

Enterovirus 71 2C protein inhibits TNF-α-mediated activation of NF-κB by suppressing IκB kinase β phosphorylation.

Zheng Z, Li H, Zhang Z, Meng J, Mao D, Bai B, Lu B, Mao P, Hu Q, Wang H.

J Immunol. 2011 Sep 1;187(5):2202-12. doi: 10.4049/jimmunol.1100285. Epub 2011 Aug 1.

10.

Transcriptional machinery of TNF-α-inducible YTH domain containing 2 (YTHDC2) gene.

Tanabe A, Konno J, Tanikawa K, Sahara H.

Gene. 2014 Feb 1;535(1):24-32. doi: 10.1016/j.gene.2013.11.005. Epub 2013 Nov 21.

PMID:
24269672
11.

Regulation and function of IKK and IKK-related kinases.

Häcker H, Karin M.

Sci STKE. 2006 Oct 17;2006(357):re13. Review.

PMID:
17047224
12.

Suppressed NF-kappaB and sustained JNK activation contribute to the sensitization effect of parthenolide to TNF-alpha-induced apoptosis in human cancer cells.

Zhang S, Lin ZN, Yang CF, Shi X, Ong CN, Shen HM.

Carcinogenesis. 2004 Nov;25(11):2191-9. Epub 2004 Jul 15.

PMID:
15256485
14.

Molecular determinants of kinase pathway activation by Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand.

Varfolomeev E, Maecker H, Sharp D, Lawrence D, Renz M, Vucic D, Ashkenazi A.

J Biol Chem. 2005 Dec 9;280(49):40599-608. Epub 2005 Oct 15.

15.

Tanshinone IIA inhibits LPS-induced NF-kappaB activation in RAW 264.7 cells: possible involvement of the NIK-IKK, ERK1/2, p38 and JNK pathways.

Jang SI, Kim HJ, Kim YJ, Jeong SI, You YO.

Eur J Pharmacol. 2006 Aug 7;542(1-3):1-7. Epub 2006 May 6.

PMID:
16797002
16.
18.

TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.

Kanazawa K, Kudo A.

J Bone Miner Res. 2005 May;20(5):840-7. Epub 2004 Dec 20.

19.

Diclofenac inhibits tumor necrosis factor-α-induced nuclear factor-κB activation causing synergistic hepatocyte apoptosis.

Fredriksson L, Herpers B, Benedetti G, Matadin Q, Puigvert JC, de Bont H, Dragovic S, Vermeulen NP, Commandeur JN, Danen E, de Graauw M, van de Water B.

Hepatology. 2011 Jun;53(6):2027-41. doi: 10.1002/hep.24314.

PMID:
21433042
20.

Effect of interaction between hepatitis C virus NS5A and NS5B on hepatitis C virus RNA replication with the hepatitis C virus replicon.

Shimakami T, Hijikata M, Luo H, Ma YY, Kaneko S, Shimotohno K, Murakami S.

J Virol. 2004 Mar;78(6):2738-48.

Supplemental Content

Support Center